• Research and Demonstration Projects: Nigeria is host to a PrEP demonstration project among serodiscordant couples at sites in Plateau, Edo and Cross River State. It is scheduled to run from late-2015 until late-2017.
  • Drug Registration:Truvada is registered for treatment. Gilead submitted an application for Truvada as PrEP to Nigeria’s regulatory authority, and is awaiting approval.
  • Policy/Regulatory: PrEP is recommended in the “National Guidelines For HIV Prevention, Treatment and Care” which state, “pre-exposure prophylaxis (PrEP) should be offered as an additional prevention choice for HIV negative persons who are exposed to prolonged and substantial risk of acquiring HIV infection as a part of a combination of other available HIV prevention methods”.
  • Advocacy: The New HIV Vaccine and Microbicide Advocacy Society (NHVMAS) has a long history advocating for research on and implementation of new HIV prevention options. Visit them here for more on their work in this space. If you’re a Nigerian advocate working on PrEP, building a campaign or seeking to share insights and experience, please send info here and PrEPWatch will post it.

Last updated on September 1, 2017.

News Spotlight